Complete Response Letters

AuroMedics Pharma LLC: Cyclophosphamide

What FDA's Complete Response Letters to the company say, in the letters' own words.

EphemerisX Research · Sep 30, 2026 · Sources: FDA, SEC

Complete Response Letter, Oct 1, 2019

No complete sentence from this letter is available from the knowledge graph yet.

Cosmetic Act for Cyclophosphamide Solution, 500 mg/2.5 mL and 1 g/5 mL.

Complete Response Letter · Jan 15, 2019 · p. 7Open the letter at p. 7 ↗CRL_NDA210735_20190115:p1:s14

Upon resubmission of your application, you must submit a revised proposed label that is current with any revisions in the reference listed drug.

Complete Response Letter · Jan 15, 2019 · p. 9Open the letter at p. 9 ↗CRL_NDA210735_20190115:p2:s17

No complete sentence from this letter is available from the knowledge graph yet.

Updated Sep 30, 2026 · built from 283 companies in the EphemerisX knowledge graph. This page is regenerated as companies are added.